Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist used in the treatment of diabetes, also activates Nrf2 leading to an increase in antioxidant and anti-inflammatory defenses. The gene discussed is NFE2L2; the disease is diabetes mellitus.